Joel Greenblatt's RVMD Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 125,901 shares of Revolution Medicines, Inc. (RVMD) worth $12.24 M, representing 0.04% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in RVMD for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 14,715 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Revolution Medicines (RVMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Revolution Medicines (RVMD) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +12,072 | Add 10.61% | 125,901 | $97.25 |
| Q4 2025 | +14,715 | Add 14.85% | 113,829 | $79.65 |
| Q3 2025 | +99,114 | New Buy | 99,114 | $46.70 |
Joel Greenblatt's Revolution Medicines Investment FAQs
Joel Greenblatt first purchased Revolution Medicines, Inc. (RVMD) in Q3 2025, acquiring 99,114 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Revolution Medicines, Inc. (RVMD) for 3 quarters since Q3 2025.
Joel Greenblatt's largest addition to Revolution Medicines, Inc. (RVMD) was in Q3 2025, adding 99,114 shares worth $4.63 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 125,901 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $12.24 M.
As of the Q1 2026 filing, Revolution Medicines, Inc. (RVMD) represents approximately 0.04% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Revolution Medicines, Inc. (RVMD) was 125,901 shares, as reported at the end of Q1 2026.